-Advertisement-
-Advertisement-
Autoimmune

Filgotinib shows consistent efficacy in rheumatoid arthritis, regardless of BMI changes
The rheumatoid arthritis (RA) medication filgotinib demonstrated consistent efficacy across various body mass index (BMI) ranges, according to a study that found that changes in BMI were minimal for most patients, and these variations did not significantly impact the effectiveness of filgotinib. However, it was noted that with higher doses...
Read More-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
Stay Connected! Join Our Newsletter
Contact
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]
© 2023 Med Journal 360™ is a trademark of International Healthcare Media, LLC. All rights Reserved